It is common for patients initially diagnosed with lung cancer to have the cancer spread to sites like the liver, brain and bone. One of the most frequent sites of metastases is the bone, with an ...

Erleada plus ADT may provide limited benefits for mCSPC patients with fewer bone metastases, affecting PFS2 and OS outcomes. Baseline bone metastasis count could guide treatment optimization for mCSPC ...

For many people, cancer is thought of as a disease that stays confined to one part of the body. However, some cancers have the ability to spread beyond where they first began. When cancer cells travel ...

The American Society of Clinical Oncology first published evidence-based practice guidelines for the use of bisphosphonates in breast cancer in 2000 and updated them in 2003. To reflect the proven ...

Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients with solid tumors and bone lesions associated with multiple myeloma.

Researchers at Rice University and Baylor College of Medicine are developing a novel antibody therapy to treat bone metastases in estrogen receptor-positive (ER+) breast cancer, backed by a $2.3 ...

When an increase in serum calcium (Ca) is found in a cancer patient, if there is bone metastasis, one is tempted to think ...

A new laboratory technique developed by researchers at Baylor College of Medicine and other institutions can rapidly test the effectiveness of treatments for life-threatening breast cancer metastases ...

The bone metastasis in solid tumors market is expected to evolve significantly over the forecast period, driven by rising cancer incidence, improved survival rates, increasing prevalence of metastatic ...

Dublin, April 23, 2026 (GLOBE NEWSWIRE)-- The "Bone Metastasis in Solid Tumors Market - A Global and Regional Analysis: Focus on Country and Region, 2025-2035" report has been added to ...